BrightSpring Health Services, Inc. $BTSG Shares Sold by Hussman Strategic Advisors Inc.

Hussman Strategic Advisors Inc. lowered its stake in shares of BrightSpring Health Services, Inc. (NASDAQ:BTSG) by 60.0% in the second quarter, according to its most recent 13F filing with the SEC. The fund owned 42,000 shares of the company’s stock after selling 63,000 shares during the period. Hussman Strategic Advisors Inc.’s holdings in BrightSpring Health Services were worth $991,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the stock. Vanguard Group Inc. raised its position in BrightSpring Health Services by 24.6% during the first quarter. Vanguard Group Inc. now owns 6,633,744 shares of the company’s stock valued at $120,004,000 after acquiring an additional 1,308,651 shares in the last quarter. Invesco Ltd. increased its holdings in shares of BrightSpring Health Services by 41.0% during the 1st quarter. Invesco Ltd. now owns 6,172,597 shares of the company’s stock valued at $111,662,000 after purchasing an additional 1,794,035 shares in the last quarter. T. Rowe Price Investment Management Inc. lifted its stake in shares of BrightSpring Health Services by 264.7% in the 1st quarter. T. Rowe Price Investment Management Inc. now owns 5,772,772 shares of the company’s stock valued at $104,430,000 after purchasing an additional 4,189,805 shares during the period. Nuveen LLC purchased a new stake in BrightSpring Health Services during the first quarter worth $29,333,000. Finally, Adage Capital Partners GP L.L.C. grew its position in BrightSpring Health Services by 145.1% during the first quarter. Adage Capital Partners GP L.L.C. now owns 939,529 shares of the company’s stock valued at $16,996,000 after buying an additional 556,152 shares during the period.

Analyst Ratings Changes

BTSG has been the subject of a number of analyst reports. Mizuho set a $38.00 price objective on shares of BrightSpring Health Services in a research report on Wednesday, October 29th. Morgan Stanley raised their price objective on BrightSpring Health Services from $25.00 to $32.00 and gave the company an “overweight” rating in a report on Tuesday, October 14th. Zacks Research upgraded BrightSpring Health Services from a “hold” rating to a “strong-buy” rating in a research report on Thursday, October 30th. Jefferies Financial Group set a $36.00 price target on shares of BrightSpring Health Services and gave the stock a “buy” rating in a research report on Tuesday, October 21st. Finally, UBS Group lifted their price target on BrightSpring Health Services from $35.00 to $42.00 and gave the stock a “buy” rating in a research note on Wednesday, October 29th. One research analyst has rated the stock with a Strong Buy rating, eleven have issued a Buy rating and one has given a Hold rating to the stock. According to data from MarketBeat, BrightSpring Health Services has a consensus rating of “Buy” and an average price target of $34.70.

BrightSpring Health Services Trading Down 4.4%

BTSG opened at $32.03 on Wednesday. The firm has a market capitalization of $5.78 billion, a price-to-earnings ratio of 52.51, a price-to-earnings-growth ratio of 0.59 and a beta of 2.41. The company’s 50 day simple moving average is $28.64 and its two-hundred day simple moving average is $24.11. BrightSpring Health Services, Inc. has a 1-year low of $15.26 and a 1-year high of $35.01. The company has a debt-to-equity ratio of 1.36, a current ratio of 1.79 and a quick ratio of 1.38.

BrightSpring Health Services (NASDAQ:BTSG) last posted its quarterly earnings results on Monday, October 20th. The company reported $0.30 EPS for the quarter, beating the consensus estimate of $0.27 by $0.03. BrightSpring Health Services had a return on equity of 11.61% and a net margin of 1.04%.The firm had revenue of $3.33 billion during the quarter, compared to analysts’ expectations of $3.16 billion. BrightSpring Health Services has set its Q3 2025 guidance at 0.300-0.300 EPS. FY 2025 guidance at EPS. Analysts expect that BrightSpring Health Services, Inc. will post 0.59 EPS for the current fiscal year.

Insider Buying and Selling at BrightSpring Health Services

In other news, insider Jon B. Rousseau sold 235,000 shares of BrightSpring Health Services stock in a transaction on Wednesday, October 22nd. The stock was sold at an average price of $28.78, for a total transaction of $6,763,300.00. Following the transaction, the insider owned 1,131,930 shares in the company, valued at $32,576,945.40. The trade was a 17.19% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Lisa A. Nalley sold 20,000 shares of the business’s stock in a transaction dated Wednesday, October 22nd. The shares were sold at an average price of $28.78, for a total transaction of $575,600.00. Following the transaction, the insider directly owned 131,150 shares in the company, valued at approximately $3,774,497. The trade was a 13.23% decrease in their position. The SEC filing for this sale provides additional information. 3.40% of the stock is owned by insiders.

BrightSpring Health Services Profile

BrightSpring Health Services, Inc operates a home and community-based healthcare services platform in the United States. The company's platform focuses on delivering pharmacy and provider services, including clinical and supportive care in home and community settings to Medicare, Medicaid, and insured populations.